3454-29-3

Usage

Uses

Used in Pharmaceutical Industry:
1-(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane is used as a key component in the production of pharmaceutical filler complexes. Its application is primarily due to its ability to form stable, cross-linked structures that can enhance the properties of the final product, such as improved mechanical strength, durability, and controlled release of active pharmaceutical ingredients.
The use of Trimethylolpropane Triglycidyl Ether in the pharmaceutical industry is particularly beneficial for the development of drug delivery systems, as it allows for the creation of matrices that can provide a sustained release of medications over time. This can lead to improved patient compliance and more effective treatment outcomes.
Additionally, the compound's reactivity and compatibility with various materials make it a valuable asset in the development of other medical devices and products, such as dental materials, orthopedic implants, and tissue engineering scaffolds.

InChI:InChI=1/C15H26O6/c1-2-15(9-16-3-12-6-19-12,10-17-4-13-7-20-13)11-18-5-14-8-21-14/h12-14H,2-11H2,1H3

Upstream product

• 77-99-6 1,1,1-tri(hydroxymethyl)propane 
• 106-89-8 epichlorohydrin 
• 682-08-6 trimethylolpropane triallyl ether 

Downstream Products

• 1300114-72-0 C₅₇H₇₁N₃O₆ 

Relevant academic research and scientific papers

BIO-NANO POWER CELLS AND THEIR USES

The present invention concerns bio-nano power cells and methods of their manufacture and use. More particularly, the present invention relates to the preparation of bio-nano power cells that are biocompatible and capable of producing flash, intermittent, or continuous power by electrolyzing compounds in biological systems.

METHOD FOR PRODUCING EPOXY COMPOUND BY OXIDATION

The present invention provides a method for producing an epoxy compound by oxidation using hydrogen peroxide, in which the generation of oxygen due to the decomposition of hydrogen peroxide can be suppressed in the system, and which does not require complicated post-treatment, is excellent in reactivity, and allows the reaction to be performed in a SUS vessel. The present invention relates to a method for producing an epoxy compound, the method comprising reacting an olefin compound with hydrogen peroxide in the presence of a nitrile compound and a silicate. The silicate is preferably at least one selected from sodium silicate and potassium silicate.

Dendritic polymers with enhanced amplification and interior functionality

Poly(ester-acrylate) and poly(ester/epoxide) dendrimers. These materials can be synthesized by utilizing the so-called “sterically induced stoichiometric” principles. The preparation of the dendrimers is carried out by reacting precursor amino/polyamino-functional core materials with various branch cell reagents. The branch cell reagents are dimensionally large, relative to the amino/polyamino-initiator core and when reacted, produce generation=1 dendrimers directly in one step. There is also a method by which the dendrimers can be stabilized and that method is the reaction of the dendrimers with surface reactive molecules to pacify the reactive groups on the dendrimers.

Amid group-containing diisocyanates and amide group-containing epoxy resins

An amide group-containing epoxy resin obtained by reacting an epoxy resin with an amide group-containing diisocyanate obtained by reacting a diisocyanate with a dicarboxylic acid gives a uniform cured article showing high adhesiveness and is usable as an adhesive, a coating composition, and the like.

A facile synthesis of polyglycidyl ethers from polyols and epichlorohydrin

The reaction of 1,1,1-tris(hydroxymethyl)ethane (1a), 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (1b), pentaerythritol (1c), or 1,2,6-hexanetriol (1e) with epichlorohydrin in the presence of potassium hydroxide in dimethyl sulfoxide gave the corresponding tri- or tetraglycidyl ethers 3a-c, e in high yields. This procedure was also applicable to the preparation of the phenolic polyglycidyl ethers.

Process for the preparation of glycidyl ethers

An improved process for the preparation of glycidyl ethers of formula I STR1 wherein Q is an aliphatic, cycloaliphatic or araliphatic radical of a valency m, R is --H or --CH3, and m is an integer from 1 to 10, by reacting an alcohol of formula Q--(OH)m with m mol of an epihalohydrin of formula II STR2 in the presence of a catalyst to the corresponding halohydrin ether, and dehydrohalogenating said halohydrin ether with an alkali metal hydroxide to give a compound of formula I, wherein Q, m and R are as defined above and Hal is halogen, which process comprises using as catalyst a) tin difluoride or b) a divalent tin halide in conjunction with a co-catalyst.